On May 9, 2025, HC Wainwright & Co. analyst Sean Lee maintained a "Buy" rating on Verastem (VSTM, Financial). The financial services firm raised its price target for VSTM from $10.00 to $14.00 USD, indicating a 40% increase in valuation. This adjustment reflects a significant vote of confidence in the company's future performance.
The previous price target set by HC Wainwright & Co was $10.00 USD, and the newly adjusted target of $14.00 USD showcases a positive outlook for Verastem's growth potential. The analyst's decision to maintain the "Buy" rating alongside a raised price target highlights continued optimism about the company's trajectory.
Investors and market watchers will be keeping a close eye on VSTM to see how the stock responds to this revised assessment in the coming weeks.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 8 analysts, the average target price for Verastem Inc (VSTM, Financial) is $14.25 with a high estimate of $20.00 and a low estimate of $8.00. The average target implies an upside of 105.33% from the current price of $6.94. More detailed estimate data can be found on the Verastem Inc (VSTM) Forecast page.
Based on the consensus recommendation from 9 brokerage firms, Verastem Inc's (VSTM, Financial) average brokerage recommendation is currently 1.7, indicating "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
